Nephro Care India Limited — Board Meeting, 13-02-2026: Outcome of Board Meeting
13-02-2026 | 04:54 pm
13-02-2026 | 04:54 pm
Nephro Care India's board met and approved standalone financial results for the quarter and nine months ended Dec 31, 2025. Q3 revenue was ₹22.66 Cr with a profit of ₹0.42 Cr. Nine-month revenue reached ₹61.98 Cr, posting a profit of ₹2.36 Cr.
No comments yet. Be the first to comment!
